About Curoverse
Curoverse is a company based in Boston (United States) founded in 2010 was acquired by Veritas Genetics in August 2017. Curoverse has raised $1.7 million across 3 funding rounds from investors including Veritas Genetics, HHS and Hatteras Venture Partners. Curoverse offers products and services including Arvados. Curoverse operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter Boston, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gorillaspace Pte. Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.7 M (USD)
in 3 rounds
-
Latest Funding Round
$500 K (USD), Debt – Conventional
Mar 24, 2015
-
Investors
Veritas Genetics
& 6 more
-
Employee Count
Not available
-
Acquired by
Veritas Genetics
(Aug 03, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curoverse
Curoverse offers a comprehensive portfolio of products and services, including Arvados.
Platform for managing and processing large biomedical data sets securely.
Funding Insights of Curoverse
Curoverse has successfully raised a total of $1.7M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $500 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Curoverse
Curoverse has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Veritas Genetics, HHS and Hatteras Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked | |
|
Tech focused early stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Curoverse
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curoverse
Investment portfolio details for Curoverse
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curoverse
Detailed financials for Curoverse
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curoverse Comparisons
Peer comparison for Curoverse
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curoverse
Curoverse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of Curoverse
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curoverse
Complete news archive for Curoverse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curoverse
Curoverse was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Curoverse is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Curoverse is a funded company, having raised a total of $1.7M across 3 funding rounds to date.
Curoverse was founded in 2010 in Boston, United States, within the genomic and biomedical sector. Open source software is utilized entirely in its platform. Arvados, a free and open source system originally developed for the Harvard Personal Genome Project, forms its core. Data management, computation, and sharing needs specific to genomic and biomedical data are handled through this infrastructure, supporting research operations across the field.
Curoverse's top competitors include Helix, Benchling and BioAge Labs.
Curoverse offers Arvados.
Curoverse has 7 investors. Key investors include Veritas Genetics, HHS, Hatteras Venture Partners, MassVentures, and Boston Global Ventures.